Episode Details

NHS Pauses Gender Hormone Treatments for Under-18s: A 90-day Consultation Begins

The NHS has temporarily halted new prescriptions of masculinizing or feminizing hormones for individuals under eighteen, following a review that found insufficient evidence to support the treatments benefits or risks for children with gender dysphoria. This decision primarily impacts sixteen and seventeen-year-olds who meet specific criteria, with new referrals ceasing as of Monday. Teens already on hormones can continue receiving them, but each case requires a new evaluation by doctors. The Cass Review recommended extreme caution before administering hormones to teens, emphasizing the need for clear reasons rather than waiting until age eighteen. A 90-day consultation is now underway to determine if these treatments should remain routine NHS care, with the pause in effect until thousands of responses are reviewed. The NHS continues to offer mental health support and gender services for young people.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/417f0750c12569d8